You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TALWIN COMPOUND Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Talwin Compound, and what generic alternatives are available?

Talwin Compound is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in TALWIN COMPOUND is aspirin; pentazocine hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; pentazocine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TALWIN COMPOUND?
  • What are the global sales for TALWIN COMPOUND?
  • What is Average Wholesale Price for TALWIN COMPOUND?
Summary for TALWIN COMPOUND
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:TALWIN COMPOUND at DailyMed
Drug patent expirations by year for TALWIN COMPOUND

US Patents and Regulatory Information for TALWIN COMPOUND

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us TALWIN COMPOUND aspirin; pentazocine hydrochloride TABLET;ORAL 016891-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TALWIN COMPOUND

See the table below for patents covering TALWIN COMPOUND around the world.

Country Patent Number Title Estimated Expiration
Sweden 306741 ⤷  Sign Up
Denmark 103236 ⤷  Sign Up
Malaysia 6600127 1,2,3,4,5,6 - HEXAHYDRO-2,6-METHANO-3-BENZAZOCINES ⤷  Sign Up
Netherlands 6705466 ⤷  Sign Up
Austria 252248 ⤷  Sign Up
Germany 1445153 1,2,3,4,5,6-HEXAHYDRO-3-(3-METHYL-2BUTENYL)-6,11-DIMETHYL-8-HYDROXY-2,6METHANO-3-BENZAZOCIN, SEINE SAEUREADDITIONSSALZE UND VERFAHREN ZU IHRER HERSTELLUNG ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.